Dorsey Wright & Associates Invests $54,000 in AnaptysBio, Inc. (NASDAQ:ANAB)
Dorsey Wright & Associates bought a new position in AnaptysBio, Inc. (NASDAQ:ANAB – Get Rating) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,548 shares of the biotechnology company’s stock, valued at approximately $54,000. Several other institutional investors and hedge funds […]